This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher Scientific (TMO) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $537.36, moving +1.61% from the previous trading session.
Select Medical (SEM) Unveils Separation Plan for Concentra
by Zacks Equity Research
Select Medical (SEM) intends to separate its Concentra business in a bid to enhance shareholder value and boost growth prospects of strategically prioritized areas.
Thermo Fisher (TMO) End Markets Drive Growth Amid Macro Woes
by Zacks Equity Research
In the academic and government end markets, Thermo Fisher (TMO) is delivering strong growth in the electron microscopy, chromatography and mass spectrometry businesses.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $531.65, denoting a +0.37% change from the preceding trading day.
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance Platform
by Zacks Equity Research
Thermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries.
Thermo Fisher's (TMO) PPD Business Backs BARDA's Clinical Trial
by Zacks Equity Research
Thermo Fisher's (TMO) PPD clinical research business is selected by BARDA to support the Phase II platform clinical trial to treat ARDS.
Why Thermo Fisher Scientific (TMO) Dipped More Than Broader Market Today
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $519.43 at the closing of the latest trading day, reflecting a -1.65% change compared to its last close.
Thermo Fisher (TMO) to Allocate IFA Testing Kits With New Pact
by Zacks Equity Research
Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $521.52 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
Thermo Fisher (TMO) Launches New Solutions for Clinical Labs
by Zacks Equity Research
Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.
New Strong Sell Stocks for December 6th
by Zacks Equity Research
AESI, EQH and TMO have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2023.
Thermo Fisher (TMO) Advances Health Equity via New Partnership
by Zacks Equity Research
Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.
Idexx (IDXX) Up 11.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thermo Fisher (TMO) Extends Partnership With Flagship Pioneering
by Zacks Equity Research
Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.
Why Is Thermo Fisher (TMO) Up 10.8% Since Last Earnings Report?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dell Technologies and Thermo Fisher Scientific have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Dell Technologies and Thermo Fisher Scientific are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Thermo Fisher Scientific (TMO)
by Derek Lewis
Recent guidance cuts stemming from a challenging macroeconomic environment have caused shares to face adverse price action over recent months.
Market Awaits After-Hours Earnings Results
by Zacks Equity Research
Market Awaits After-Hours Earnings Results.
Q3 Earnings Mixed, Big Results Expected After-Hours
by Mark Vickery
The Dow is the sole major index in the green this morning, boosted by Microsoft's strong performance yesterday afternoon.
Thermo Fisher (TMO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Thermo Fisher's (TMO) PPI Business System and strong execution by its global team enabled the company to deliver strong financial performance for Q3.
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.97% and 0.04%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
The latest trading day saw Thermo Fisher Scientific (TMO) settling at $469.67, representing a +0.52% change from its previous close.
DexCom (DXCM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Thermo Fisher (TMO) in Q3 Earnings?
by Zacks Equity Research
Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and latest launches.